Hamps Bio share price
BSE: 544312Agricultural Food & other ProductsSmall Cap
Last close ₹25.00₹0.00 (0.00%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹25.00.
52-week range of traded prices to 23 Oct 2026
₹13.36Low, 24 Mar 2026₹26.58High, 30 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹22 Cr4,207th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 2.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 29 May 2026
- −9.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.85
- Volume, BSEVolume. Shares traded on the last trading day.
- 4,000
Results
Standalone, as consolidated accounts are on record for only 1 of the last ten years; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 29 May
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹4.53 Crup 13.37%
- Net profitNet profit. Under it, net profit in the half year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹0.46 CrHalf year to Sep 2025: −₹0.20 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −10.2%
Revenue by year
Peak revenue ₹8.52 Cr, year to Mar 2026
Net profit by year, a loss in red
- Net profit
- Loss
A loss in the year to Mar 2026, −₹0.66 Cr
| ₹ crore | Sep 2024Filed 30 May | Mar 2025Filed 30 May | Sep 2025Filed 14 Nov | Mar 2026Filed 29 May |
|---|---|---|---|---|
| Revenue | 3.54 | 3.13 | 3.99 | 4.53 |
| Net profit | 0.26 | 0.03 | −0.20 | −0.46 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 7.5% | 1.0% | −4.9% | −10.2% |
Standalone. The 4 half years from Sep 2024, the first on record. The latest is shaded.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Freeze dried ProductsFreeze dried Products, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹6.53 Cr59.5%
- Pharmaceutical ProductsPharmaceutical Products, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹4.44 Cr40.5%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −22.6% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Peers and competitors
Other Agricultural Products, 93 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Hamps Bio in market cap. 1 company in the table last traded before then: its row is priced on its last trade.
Hamps Bio is not on the chart: it has no P/E today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 NFP Sampoorna FoodsNFPSAMPOOR | 25 | 5.5 | – | – | – | – | 27.2% | – | 0.00% |
 Prospect Consumer ProductsPCL | 24 | 10.0 | 0.8 | – | +85.7% | +14.8% | 8.8% | – | 0.00% |
 Sameera Agro and InfraSAIFL | 24 | – | – | – | – | – | – | – | 0.00% |
 Sunil Agro FoodsSUNILAGR | 22 | 47.1 | 1.3 | 12.7 | −20.4% | – | 2.9% | 5.8% | 0.00% |
 Harshil AgrotechHARSHILAGR | 21 | – | – | – | – | – | – | – | 0.00% |
 Natura Hue ChemNATHUEC | 19 | – | 2.0 | – | – | – | −11.8% | −13.1% | 0.00% |
 Nirman Agri GeneticsNIRMAN | 18 | 1.0 | 0.1 | – | −16.9% | −29.9% | 14.8% | – | 0.00% |
 Vikas WSPVIKASWSP | 17 | – | 0.0 | – | – | – | −7.8% | −9.7% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
Aug 2026
12 Aug · Board meeting
Jul 2026
6 Jul · Intimation-Under-Regulation-30(5)-Of-The-SEBI-LODR
Hamps Bio share price by year
Each calendar year to 2025.Hamps Bio share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 20.00 | −51.6% | 40.93 | 18.15 |
| 2024 | 41.34 | – | 53.41 | 41.34 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 20 Dec 2024.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 4,000 |
| 21 Oct 2026 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 4,000 |
| 19 Oct 2026 | 24.60 | 25.00 | 22.50 | 25.00 | 24.03 | 24,000 |
| 16 Oct 2026 | 24.60 | 24.60 | 24.00 | 24.50 | 24.37 | 12,000 |
| 14 Oct 2026 | 25.50 | 25.50 | 24.50 | 24.50 | 25.00 | 8,000 |
| 12 Oct 2026 | 22.51 | 25.90 | 22.51 | 25.50 | 24.64 | 12,000 |
| 9 Oct 2026 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 4,000 |
| 8 Oct 2026 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 4,000 |
| 5 Oct 2026 | 25.44 | 25.44 | 25.44 | 25.44 | 25.44 | 4,000 |
| 1 Oct 2026 | 22.92 | 25.44 | 22.92 | 25.44 | 24.60 | 12,000 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus share history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 8 Sep 2025 | Bonus | 0.5000 | Holders received 1 bonus share for every 1 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- Legal name
- HAMPS BIO LIMITED
- BSE code
- 544312
- ISIN
- INE0QBD01018
- Industry
- Agricultural Food & other Products
- Listed
- Dec 2024
- Face value
- ₹10
- CIN
- L24233GJ2007PLC049692
- Corporate identity number, the registrar of companies' code for it